Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trachoma: an overview.

Matthew J Burton1

  • 1International Centre for Eye Health, Department of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK. matthew.burton@lshtm.ac.uk

British Medical Bulletin
|January 8, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Head-to-Head Comparative Evaluation of Four Commercially Available Artificial Intelligence Systems for Detecting Referable Diabetic Retinopathy in a Tanzanian Population.

Diabetes care·2026
Same author

Quality-of-Life and Utility Values Associated With Diabetic Retinopathy in Tanzania.

Value in health regional issues·2026
Same author

Regional and temporal trends in antimicrobial susceptibility among isolates from bacterial keratitis: a systematic review and meta-analysis.

The Lancet. Microbe·2026
Same author

Prevalence and risk factors associated with corneal opacity in The Gambia.

The British journal of ophthalmology·2026
Same author

Baseline Predictors for the Postoperative Trachomatous Trichiasis Following Lid Rotation Surgery in the FLuorometholone as Adjunctive MEdical Therapy for Trachomatous Trichiasis Surgery (FLAME) Trial.

Ophthalmic epidemiology·2026
Same author

Evaluation of a face-washing behaviour change intervention for trachoma prevention in Oromia, Ethiopia (Stronger SAFE): secondary outcomes of a cluster-randomised controlled trial.

The Lancet. Global health·2026
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Trachoma, a leading infectious cause of blindness, is caused by Chlamydia trachomatis. The SAFE strategy aims to eliminate blinding trachoma, but evidence gaps remain for optimal management.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Public Health

Background:

  • Trachoma is the leading infectious cause of preventable blindness globally.
  • It disproportionately affects impoverished regions in Africa and Asia.
  • Caused by Chlamydia trachomatis, it leads to conjunctival scarring, eyelid distortion (entropion), and eyelash abrasion (trichiasis), resulting in corneal opacification and blindness.

Purpose of the Study:

  • To summarize the current understanding of trachoma and the global efforts to eliminate it.
  • To highlight the World Health Organization's SAFE strategy for trachoma elimination.
  • To identify existing gaps in evidence and uncertainties regarding optimal trachoma management.

Main Methods:

  • Review of existing literature on trachoma epidemiology and pathogenesis.

Related Experiment Videos

  • Analysis of the components and implementation of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvements).
  • Identification of areas requiring further research for improved trachoma control.

    • Main Results:

    • Trachoma is a significant global health burden, particularly in developing countries.
    • The SAFE strategy has shown some success in reducing trachoma prevalence.
    • Significant gaps in the evidence base hinder the determination of optimal management strategies.

    Conclusions:

    • While progress has been made, trachoma remains a major cause of blindness.
    • Further research is crucial to refine management protocols and achieve global elimination goals.
    • Integrated public health approaches are essential for controlling trachoma transmission and impact.